Catherine Gutierrez, M.D.,Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2021 | 1514 | 1.280 |
Why?
|
| Quinazolinones | 1 | 2019 | 223 | 0.650 |
Why?
|
| Purines | 1 | 2019 | 589 | 0.580 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1780 | 0.450 |
Why?
|
| Government Regulation | 1 | 2016 | 546 | 0.420 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2532 | 0.400 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 885 | 0.380 |
Why?
|
| Sulfonamides | 1 | 2019 | 1922 | 0.380 |
Why?
|
| Pyrazoles | 1 | 2019 | 1958 | 0.360 |
Why?
|
| Clone Cells | 2 | 2022 | 1760 | 0.330 |
Why?
|
| Pyrimidines | 1 | 2019 | 2930 | 0.320 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 1794 | 0.270 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6324 | 0.270 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6592 | 0.230 |
Why?
|
| Models, Biological | 1 | 2019 | 9809 | 0.230 |
Why?
|
| Ikaros Transcription Factor | 1 | 2021 | 221 | 0.190 |
Why?
|
| DNA Mismatch Repair | 1 | 2023 | 408 | 0.180 |
Why?
|
| Microsatellite Instability | 1 | 2023 | 664 | 0.180 |
Why?
|
| Mutation | 3 | 2022 | 29290 | 0.180 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13626 | 0.170 |
Why?
|
| Craniopharyngioma | 1 | 2021 | 278 | 0.170 |
Why?
|
| Astrocytoma | 1 | 2022 | 792 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7499 | 0.150 |
Why?
|
| Receptors, Notch | 1 | 2021 | 754 | 0.150 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 657 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 987 | 0.140 |
Why?
|
| Adenine | 1 | 2019 | 897 | 0.130 |
Why?
|
| Genomics | 2 | 2021 | 5342 | 0.130 |
Why?
|
| Receptors, LDL | 1 | 2017 | 522 | 0.130 |
Why?
|
| Neoplasms | 1 | 2022 | 20528 | 0.120 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1292 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 1216 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 512 | 0.110 |
Why?
|
| Lysosomes | 1 | 2017 | 894 | 0.110 |
Why?
|
| Piperidines | 1 | 2019 | 1582 | 0.100 |
Why?
|
| Adenoma | 1 | 2021 | 2119 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 1670 | 0.100 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 1003 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2985 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2129 | 0.090 |
Why?
|
| Cell Line | 2 | 2021 | 16575 | 0.090 |
Why?
|
| Cholesterol | 1 | 2017 | 2866 | 0.080 |
Why?
|
| Glioma | 1 | 2022 | 3302 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2022 | 3346 | 0.080 |
Why?
|
| Biopsy | 1 | 2019 | 6737 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4902 | 0.080 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 1904 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3428 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7885 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5198 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3824 | 0.070 |
Why?
|
| Prevalence | 1 | 2023 | 14912 | 0.070 |
Why?
|
| Humans | 11 | 2023 | 715818 | 0.070 |
Why?
|
| Prognosis | 2 | 2023 | 29007 | 0.070 |
Why?
|
| United States | 3 | 2023 | 67910 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2017 | 5101 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18197 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 8805 | 0.050 |
Why?
|
| Daptomycin | 1 | 2021 | 78 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 11940 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 561 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2022 | 839 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 2787 | 0.040 |
Why?
|
| World Health Organization | 1 | 2021 | 1286 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 214666 | 0.030 |
Why?
|
| Male | 4 | 2021 | 350352 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6482 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3633 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2021 | 2553 | 0.030 |
Why?
|
| Female | 3 | 2023 | 377229 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 212279 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 13213 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 2977 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3332 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 15058 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10615 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8571 | 0.020 |
Why?
|
| Apoptosis | 1 | 2021 | 9971 | 0.020 |
Why?
|
| Mice | 2 | 2021 | 80373 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7095 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22663 | 0.010 |
Why?
|
| Animals | 2 | 2021 | 169404 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23729 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 56228 | 0.010 |
Why?
|
| Child | 1 | 2022 | 74468 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 85157 | 0.010 |
Why?
|